Participants are randomized 1:1 to receive D+Q or placebo administered for two consecutive days out of every fifteen days across three months with an extended nine-month follow-up after the intervention
While plant-based protein sources are known to benefit cardiovascular health, increased intake of animal protein has been linked to CVD and all-cause mortality (26, 27)
However, repeated missed doses may reduce appetite suppression and metabolic benefits over time, requiring provider reassessment
Schedule: Daily subcutaneous injections for 1226 weeks (extendable to 52 weeks with medical supervision) [3]
Rouru, J., Isaksson, K., Santti, E., Huupponen, R
With its focus on slowing gastric emptying and moderating insulin release, tirzepatide ensures full efficacy for both diabetes and weight loss contexts, making the switch between Mounjaro vs Zepbound a consideration of conditions more than efficacy